EI

Eifelhoehen-Klinik AGFRA Eifelhoehen-Klinik Stock Report

Last reporting period 30 Jun, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

0.01

Micro

Exchange

XFRA - Deutsche Boerse AG

EIF.F Stock Analysis

EI

Uncovered

Eifelhoehen-Klinik AG is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-13/100

Low score

Market cap $B

0.01

Dividend yield

7.18 %

Shares outstanding

3.12 B

Eifelhöhen-Klinik AG operates facilities for the provision of inpatient and outpatient rehabilitation, elderly care, and outpatient medical care. The company is headquartered in Bonn, Nordrhein-Westfalen and currently employs 384 full-time employees. The company went IPO on 2012-04-03. The company operates the Eifelhoehen-Klinik Marmagen GmbH in Nettersheim-Marmagen, a specialist clinic for outpatient and inpatient internal medicine, orthopedics/traumatology, neurology; the Kaiser-Karl-Klinik GmbH in Bonn, a specialist clinic for outpatient and inpatient orthopedics, geriatrics and internal medicine, as well as the Herzpark Moenchengladbach GmbH in Moenchengladbach, a specialist clinic for outpatient and inpatient cardiac rehabilitation. In addition to that it owns a majority stake in Aatalklinik Wuennenberg GmbH and a minority stake in geriatric center Zuelpich GmbH.

View Section: Eyestock Rating